Vanguard Group Inc Alnylam Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,994,261 shares of ALNY stock, worth $2.88 Billion. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,994,261
Previous 11,943,895
0.42%
Holding current value
$2.88 Billion
Previous $2.29 Billion
21.59%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding ALNY
# of Institutions
584Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.07 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.17 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.73 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.59 Billion0.78% of portfolio
-
Dodge & Cox San Francisco, CA3.81MShares$915 Million0.35% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...